Winway Health Desk
BI, Gilead execs highlight value of disease awareness campaigns—particularly during the...
Disease awareness campaigns need to go where the patients are, and today that means digital.
That’s even more relevant now during the COVID-19 pandemic, Gilead...
AstraZeneca, Daiichi’s Enhertu steps into the FDA’s fast lane for new...
AstraZeneca and Daiichi Sankyo are rapidly gaining traction for their Enhertu in HER2-positive breast cancer. Next up? An early chance at expanding the blockbuster-to-be into...
7 best practices for pharmacies managing short-dated inventory
As with any perishable item, short-dated drugs are more prone to the risk of destruction if they are not managed appropriately. These medications should...
Conversion Story: Reconfiguring A Decommissioned Facility Into An Alternate Care Facility
With only four weeks to convert a vacant medical office building into an alternate care facility (ACF), a project on the site of the...
Skin-checking app sees future in clinicians, not automation
Miiskin’s skin mapping tool highlights moles and marks, making it easier to detect new ones. Photo credit: Miiskin
While a swath of skin startups tout...
Alexion Receives FDA Approval for New Advanced Formulation of Ultomiris (ravulizumab-cwvz)...
BOSTON--(BUSINESS WIRE)--Oct. 12, 2020-- Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz) 100 mg/mL formulation...
Harmony Biosciences Receives FDA Approval for Expanded Use of Wakix (pitolisant)...
PLYMOUTH MEETING, PA and CHICAGO, IL, October 13, 2020 — Harmony Biosciences Holdings, Inc. ("Harmony") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and...
FDA Approves Sklice (ivermectin) Lotion for Nonprescription Use to Treat Head...
October 27, 2020 -- Today, the U.S. Food and Drug Administration approved a lotion to treat head lice for nonprescription, or over-the-counter (OTC), use...
FDA nails Pennsylvania generics maker with 2nd warning letter in a...
An FDA warning letter is an ignominious sign for any company and a wake-up call for change. But two warning letters in one year?...
Honor raises $140M to grow home-care network
In the fragmented home-care space, San Francisco-based startup Honor is trying to bring together more caregivers under one company. The idea is to reach...
